VENABLE LLP

Lobbying for GENEOSCOPY · Life sciences company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Missouri · House · Senate · $20,000.00 income · posted Jan 12, 2026

Lobbying activity 2

Health Issues

Increasing access to colorectal cancer screening; Medicare coverage of colorectal cancer screening tests; USPSTF colorectal cancer screening guidelines; Medicare Quality Measures; Commercial coverage of colorectal cancer screening

Budget/Appropriations

FY 2026 VA Appropriations Expanding colorectal cancer screening for veterans

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.